New Results
TNFRSF14 (HVEM) is a novel immune checkpoint blockade that can be targeted by a monoclonal antibody to improve anti-tumor response in humanized mice
S. Brunel, N. Aubert, D. Olive, View ORCID ProfileG. Marodon
doi: https://doi.org/10.1101/711119
S. Brunel
1Sorbonne Universités, Inserm, CNRS, Centre d’immunologie et maladies infectieuses-Paris, Cimi-Paris, Paris 75013, France
N. Aubert
1Sorbonne Universités, Inserm, CNRS, Centre d’immunologie et maladies infectieuses-Paris, Cimi-Paris, Paris 75013, France
D. Olive
2Institut Paoli-Calmettes, Aix-Marseille Université, Inserm, CNRS, CRCM, Tumor Immunity Team, IBISA Immunomonitoring platform, Marseille, France
G. Marodon
1Sorbonne Universités, Inserm, CNRS, Centre d’immunologie et maladies infectieuses-Paris, Cimi-Paris, Paris 75013, France
Posted January 23, 2020.
TNFRSF14 (HVEM) is a novel immune checkpoint blockade that can be targeted by a monoclonal antibody to improve anti-tumor response in humanized mice
S. Brunel, N. Aubert, D. Olive, G. Marodon
bioRxiv 711119; doi: https://doi.org/10.1101/711119
Subject Area
Subject Areas
- Biochemistry (11752)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14974)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28097)
- Molecular Biology (11594)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2886)
- Systems Biology (7340)
- Zoology (1651)